130 related articles for article (PubMed ID: 32171988)
1. Methoxy-enriched cationic stilbenes as anticancer therapeutics.
Yousuf M; Jinka S; Adhikari SS; Banerjee R
Bioorg Chem; 2020 May; 98():103719. PubMed ID: 32171988
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of Novel Imine Stilbene Analogs Exhibiting Potent Anticancer Activity.
Naini R; Ravikumar E; Singh SS; Kancha RK; Rao KV; Reddy VD
Anticancer Agents Med Chem; 2017 Nov; 17(11):1537-1544. PubMed ID: 28356012
[TBL] [Abstract][Full Text] [Related]
3. Development of new estradiol-cationic lipid hybrids: ten-carbon twin chain cationic lipid is a more suitable partner for estradiol to elicit better anticancer activity.
Sudhakar G; Bathula SR; Banerjee R
Eur J Med Chem; 2014 Oct; 86():653-63. PubMed ID: 25222876
[TBL] [Abstract][Full Text] [Related]
4. DNA-binding affinity, cytotoxicity, apoptosis, cell cycle inhibition and molecular docking studies of a new stilbene derivative.
Mehdipour M; Dehghan G; Yekta R; Hanifeh Ahagh M; Mahdavi M; Ghasemi Z; Fathi Z
Nucleosides Nucleotides Nucleic Acids; 2019; 38(2):101-118. PubMed ID: 30931800
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Anti-cancer Activity of Stilbene and Methoxydibenzo[b,f] oxepin Derivatives.
Garbicz D; Mielecki D; Wrzesinski M; Pilzys T; Marcinkowski M; Piwowarski J; Debski J; Palak E; Szczecinski P; Krawczyk H; Grzesiuk E
Curr Cancer Drug Targets; 2018; 18(7):706-717. PubMed ID: 28669347
[TBL] [Abstract][Full Text] [Related]
7.
Rashid F; Saeed A; Iqbal J
Anticancer Agents Med Chem; 2021; 21(6):793-802. PubMed ID: 32781966
[TBL] [Abstract][Full Text] [Related]
8. Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism.
Simoni D; Roberti M; Invidiata FP; Aiello E; Aiello S; Marchetti P; Baruchello R; Eleopra M; Di Cristina A; Grimaudo S; Gebbia N; Crosta L; Dieli F; Tolomeo M
Bioorg Med Chem Lett; 2006 Jun; 16(12):3245-8. PubMed ID: 16580204
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Multifunctional Hybrid Analogs for Stilbenes, Chalcones and Flavanones.
Cagir A; Odaci B; Varol M; Akcok I; Okur O; Koparal AT
Anticancer Agents Med Chem; 2018 Feb; 17(14):1915-1923. PubMed ID: 28554313
[TBL] [Abstract][Full Text] [Related]
10. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
[TBL] [Abstract][Full Text] [Related]
11. Photoswitchable anticancer activity via trans-cis isomerization of a combretastatin A-4 analog.
Sheldon JE; Dcona MM; Lyons CE; Hackett JC; Hartman MC
Org Biomol Chem; 2016 Jan; 14(1):40-9. PubMed ID: 26503632
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents.
Conesa-Milián L; Falomir E; Murga J; Carda M; Meyen E; Liekens S; Alberto Marco J
Eur J Med Chem; 2018 Mar; 147():183-193. PubMed ID: 29432949
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Biological Evaluation of Stilbene Analogues as Hsp90 C-Terminal Inhibitors.
Byrd KM; Kent CN; Blagg BSJ
ChemMedChem; 2017 Dec; 12(24):2022-2029. PubMed ID: 29058824
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
[TBL] [Abstract][Full Text] [Related]
15. Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: structural requirements for potency.
Androutsopoulos VP; Ruparelia KC; Papakyriakou A; Filippakis H; Tsatsakis AM; Spandidos DA
Eur J Med Chem; 2011 Jun; 46(6):2586-95. PubMed ID: 21497957
[TBL] [Abstract][Full Text] [Related]
16. Target ROS to induce apoptosis and cell cycle arrest by 5,7-dimethoxy-1,4-naphthoquinone derivative.
Li K; Wang B; Zheng L; Yang K; Li Y; Hu M; He D
Bioorg Med Chem Lett; 2018 Feb; 28(3):273-277. PubMed ID: 29305189
[TBL] [Abstract][Full Text] [Related]
17. New derivatives of 4'-phenyl-2,2':6',2″-terpyridine as promising anticancer agents.
Malarz K; Zych D; Gawecki R; Kuczak M; Musioł R; Mrozek-Wilczkiewicz A
Eur J Med Chem; 2021 Feb; 212():113032. PubMed ID: 33261897
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and bio-evaluation of novel quinolino-stilbene derivatives as potential anticancer agents.
Srivastava V; Lee H
Bioorg Med Chem; 2015 Dec; 23(24):7629-40. PubMed ID: 26602827
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterisation of (Z)-styrylbenzene derivatives as potential selective anticancer agents.
Xin YB; Li JJ; Zhang HJ; Ma J; Liu X; Gong GH; Tian YS
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1554-1564. PubMed ID: 30244610
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of biaryl aryl stilbenes/ethylenes as antimicrotubule agents.
Kumar AS; Reddy MA; Jain N; Kishor C; Murthy TR; Ramesh D; Supriya B; Addlagatta A; Kalivendi SV; Sreedhar B
Eur J Med Chem; 2013 Feb; 60():305-24. PubMed ID: 23313639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
